Efficacy of favipiravir in COVID-19: A retrospective two center comparative study
Introduction: Favipiravir (FVP) is an antiviral, targeting RNA-dependent RNA polymerase. We aimed to evaluate the efficacy of FVP as a treatment for COVID-19. Methods: We conducted a retrospective study in two centers (San Martino University Hospital in Genova, Italy, and Marmara University Pendi...
Saved in:
| Main Authors: | Elif Tukenmez Tigen, Malgorzata Mikulska, Buket Erturk Sengel, Alessio Signori, Silvia Dettori, Stefania Tutino, Abdullah Emre Guner, Zekaver Odabasi, Volkan Korten, Matteo Bassetti |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2024-09-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/18039 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The safety and adverse event profile of favipiravir in the treatment of COVID-19 patients, Turkey
by: Elif Tukenmez Tigen, et al.
Published: (2023-11-01) -
A Retrospective Analysis of Treatment of Covid-19 with Favipiravir
by: Aigul Utegenova, et al.
Published: (2022-06-01) -
Antiviral and anti-inflammatory activities of favipiravir and quinine sulfate against dengue virus serotype 1 in vitro
by: Regita Aulia Rosalina, et al.
Published: (2025-03-01) -
Favipiravir for the treatment of COVID-19 pneumonia: Can we predict the response to treatment?
by: Abdullah Sayiner, et al.
Published: (2022-03-01) -
Phase I Pharmacokinetics Study of Drug for Infusion «Areplivir» (INN: Favipiravir) (LLC "PROMOMED RUS", Russia)
by: T. N. Komarov, et al.
Published: (2023-05-01)